NantHealth (NH) Tops Q2 EPS by 1c, Miss on Revenues

NantHealth (NASDAQ: NH) reported Q2 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $22 million versus the consensus estimate of $24.07 million.

“Our Software as a Service business continued to generate solid year over year revenue growth,” said Paul Holt, Chief Financial Officer of NantHealth. “Looking ahead, we are optimistic about several significant opportunities in our SaaS and software sales pipelines and the potential of our recently launched products.”

For earnings history and earnings-related data on NantHealth (NH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c